GlassScriptPhysician profile
Syed H Alam
NPI 1396179677
$718.77
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $130 · 2021: $199 · 2022: $33.64 · 2023: $172 · 2024: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $232.89 | 2020-2024 | Enbrel, Tavneos |
| Abbvie INC. | $125.59 | 2023-2024 | Skyrizi, Rinvoq |
| Glaxosmithkline, LLC. | $77.23 | 2023-2024 | Benlysta |
| Novo Nordisk INC | $76.36 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $38.45 | 2021 | |
| Lilly USA, LLC | $35.90 | 2021 | |
| Kyowa Kirin, INC. | $24.16 | 2024 | Crysvita |
| Insmed, INC. | $23.47 | 2024 | Arikayce |
| Sandoz INC. | $21.59 | 2023 | Hyrimoz |
| Exact Sciences Corporation | $19.09 | 2023 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $17.16 | 2022 | |
| Merck Sharp & Dohme LLC | $14.14 | 2021 | |
| Depuy Synthes Sales INC. | $12.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Alam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.